Raynaud Phenomenon

19 clinical trials · Condition

Record	Firm	Date
Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis (NCT05204784)	Peter Korsten	2022-02-28
Botulinum Toxin in Raynaud's Phenomenon (NCT05125029)	Emory University	2022-02-10
Dermoscopy in Primary Raynaud's Phenomenon (NCT04644523)	Assistance Publique - Hôpitaux de Paris	2021-01-01
Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon (NCT03749577)	University Hospital, Grenoble	2020-10-01
Cold Challenge With C21 in RP (NCT04388176)	Vicore Pharma AB	2020-01-03
Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon (NCT03972566)	RoseLab Skin Optics Laboratory	2019-06-20
Follow-up of SPTS in Patients With Raynaud's Phenomenon (NCT04015193)	University Medical Center Groningen	2019-03-28
Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon (NCT03699436)	Universidad de Granada	2018-10-01
Tadalafil-Delivra and Raynaud's Phenomenon (NCT03393325)	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	2018-10-01
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon (NCT03639766)	University of Central Florida	2018-08-31
Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon (NCT03129178)	University of Portsmouth	2017-07-01
Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon (NCT03094910)	Herlev Hospital	2017-01-01
Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis (NCT01347008)	Federal University of São Paulo	2011-04-01
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon (NCT01280266)	Seoul National University Hospital	2011-01-01

Track Raynaud Phenomenon automatically

Every clearance here is in the API, with alerts when new ones post.